The immune health market continues to boom as more consumers are looking for ways to enhance their immune system and stay healthy throughout the year. In this webinar learn about the newest, never before seen approach that supports the immune system. IMMUSE™ (Lactococcus lactis strain Plasma) discovered by KIRIN, acts uniquely by activating pDC (plasmacytoid dendritic cells). pDC, better-known as “commander-in-chief” of the immune system, has been known to activate pivotal cells such as NK, Killer-T, Helper-T, and B cells, providing broad-range immune support.
IMMUSE is supported by nine clinical trials consisting of seven efficacy studies and two safety studies. It is also self-affirmed GRAS and delivered in heat-killed pure powder form. Stable and applicable to wide variety of delivery formats, including tablets, capsules and foods, clinically researched IMMUSE is an efficacious immune support ingredient that can be flexibly formulated.
Join us to learn more about IMMUSE and to be part of a lively discussion on immune health market trends, the discovery of paraprobiotics for immune health, and a Q&A with a scientific researcher from KIRIN.
- An overview of today's immune health category and how to stand-out in a crowded immune-health category.
- Discover the unique mechanism of action of Lactococcus lactis strain Plasma (LC-Plasma) and the importance of pDC cells with the immune system
- Understand the functional and clinically studied health benefits of IMMUSE™, a novel paraprobiotic.